NYSE: CMAComerica Inc Stock
$54.99-2.52 (-4.38%)
Updated Jun 13, 2025
CMA Price
$54.99
Fair Value Price
N/A
Market Cap
$7.23B
52 Week Low
$45.86
52 Week High
$73.45
P/E
10.32x
P/B
1.02x
P/S
2.4x
PEG
3.66x
Dividend Yield
3.87%
Revenue
$3.23B
Earnings
$732.00M
Gross Margin
100%
Operating Margin
29.25%
Profit Margin
21.8%
Debt to Equity
10.01
Operating Cash Flow
$1B
Beta
1.24
Next Earnings
Jul 18, 2025
Ex-Dividend
Jun 13, 2025
Next Dividend
Jul 1, 2025
CMA Overview
Comerica Incorporated operates a business bank, a retail bank, and wealth management segment Locations can be found in Texas, Arizona, California, Florida, and Michigan. Formerly known as the Detroit Savings Fund Institute, Comerica was founded in 1849 and is headquartered in Dallas, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CMA's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
D
CMA
Ranked#229 of 296
Ranked#229 of 296
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $34.81 | A | |
| $36.01 | B | |
| $14.40 | B |
Be the first to know about important CMA news, forecast changes, insider trades & much more!
CMA News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CMA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CMA ($54.99) is trading above its intrinsic value of $34.66, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CMA is good value based on its earnings relative to its share price (10.32x), compared to the US market average (31.36x)
P/E vs Market Valuation
CMA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CMA due diligence checks available for Premium users.
Valuation
CMA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
10.32x
Industry
11.9x
Market
31.36x
CMA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CMA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CMA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.02x
Industry
1.15x
CMA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CMA price to earnings growth (PEG)
For valuing profitable companies with growth potential
CMA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CMA's financial health
Profit margin
Revenue
$809.0M
Net Income
$172.0M
Profit Margin
20.4%
CMA's Earnings (EBIT) of $946.00M... subscribe to Premium to read more.
Interest Coverage Financials
CMA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$77.6B
Liabilities
$70.6B
Debt to equity
10.01
CMA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CMA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$273.0M
Investing
$913.0M
Financing
-$2.2B
CMA's operating cash flow ($1.08B)... subscribe to Premium to read more.
Debt Coverage Financials
CMA vs Bank Stocks
Comerica Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.